Table 3. The impact of individual components of FLI and HSI scores on the risk for prostate cancer by multivariable analyses.
Variables | Number | Outcome | Duration | IR | HR (95% CI)a | P trend |
---|---|---|---|---|---|---|
BMI | < 0.001 | |||||
< 18.5 Kg/m2 | 252248 | 1249 | 1300796 | 0.96 | 0.77 (0.72, 0.81) | |
18.5, 23.0 Kg/m2 | 3580475 | 16757 | 19134023 | 0.88 | 1 [Reference] | |
23.0, 25.0 Kg/m2 | 2823597 | 14659 | 15165239 | 0.97 | 1.16 (1.14, 1.19) | |
25.0, 30.0 Kg/m2 | 3472109 | 16474 | 18521411 | 0.89 | 1.20 (1.17, 1.23) | |
≥ 30.0 Kg/m2 | 388556 | 1145 | 2024372 | 0.57 | 1.26 (1.18, 1.33) | |
Abdominal obesityb | < 0.001 | |||||
No | 8237809 | 35575 | 44118188 | 0.81 | 1 [Reference] | |
Yes | 2279176 | 14709 | 12027653 | 1.22 | 1.15 (1.13, 1.17) | |
Dyslipidemiac | < 0.001 | |||||
No | 6181691 | 28702 | 32986710 | 0.87 | 1 [Reference] | |
Yes | 4212159 | 21142 | 22438762 | 0.94 | 1.07 (1.06, 1.09) | |
Diabetes | < 0.001 | |||||
No | 9425273 | 40424 | 50502501 | 0.80 | 1 [Reference] | |
yes | 1091712 | 9860 | 5643340 | 1.75 | 1.05 (1.03, 1.07) | |
GGTc | < 0.001 | |||||
< 21 IU/L | 2600002 | 13157 | 13932884 | 0.94 | 1 [Reference] | |
< 31 IU/L | 2712295 | 14088 | 14590886 | 0.97 | 1.08 (1.05, 1.11) | |
< 50 IU/L | 2572446 | 12709 | 13779962 | 0.92 | 1.13 (1.10, 1.16) | |
≥ 50 IU/L | 2632242 | 10330 | 13842109 | 0.75 | 1.08 (1.05, 1.11) | |
ALT/ASTc | < 0.001 | |||||
< 0.8 | 2643673 | 16950 | 13946366 | 1.22 | 1 [Reference] | |
0.8–1.0 | 2463015 | 13489 | 13163352 | 1.02 | 1.10 (1.08, 1.13) | |
< 1.3 | 2781073 | 12479 | 14906255 | 0.84 | 1.16 (1.13, 1.19) | |
≥ 1.3 | 2629224 | 7366 | 14129868 | 0.52 | 1.14 (1.11, 1.17) | |
ALTd | < 0.001 | |||||
< 18 IU/L | 2812374 | 15345 | 14900042 | 1.03 | 1 [Reference] | |
< 24 IU/L | 2535905 | 13787 | 13597829 | 1.01 | 1.08 (1.05, 1.10) | |
< 34 IU/L | 2552043 | 12282 | 13688390 | 0.90 | 1.11 (1.08, 1.14) | |
≥ 34 IU/L | 2616663 | 8870 | 13959580 | 0.64 | 1.10 (1.07, 1.13) | |
ASTd | 0.236 | |||||
< 20 IU/L | 2526159 | 10557 | 13463044 | 0.78 | 1 [Reference] | |
< 24 IU/L | 2651440 | 12648 | 14213703 | 0.89 | 1.00 (0.97, 1.02) | |
< 30 IU/L | 2776167 | 14411 | 14891113 | 0.97 | 0.99 (0.96, 1.01) | |
≥ 30 IU/L | 2563219 | 12668 | 13577982 | 0.93 | 0.99 (0.96, 1.01) | |
FLId | < 0.001 | |||||
< 13.7 | 2629246 | 10733 | 14039989 | 0.76 | 1 [Reference] | |
< 29.4 | 2629246 | 14011 | 14123644 | 0.99 | 1.16 (1.13, 1.19) | |
< 52.7 | 2629247 | 14370 | 14087052 | 1.02 | 1.22 (1.19, 1.25) | |
≥ 52.7 | 2629246 | 11170 | 13895157 | 0.80 | 1.24 (1.21, 1.27) | |
HSId | < 0.001 | |||||
< 29.1 | 2629307 | 13744 | 13942057 | 0.99 | 1 [Reference] | |
29.1–32.2 | 2629183 | 14142 | 14091688 | 1.00 | 1.18 (1.15, 1.21) | |
32.3–36.0 | 2629265 | 13279 | 14086812 | 0.94 | 1.24 (1.21, 1.27) | |
≥ 36.0 | 2629230 | 9119 | 14025284 | 0.65 | 1.27 (1.24, 1.31) |
AST aspartate aminotransferase, ALT alanine transaminase, BMI body mass index, GGT gamma glutamyltransferase, FLI fatty liver index, HSI hepatic steatosis index, IR incidence rate, WC waist circumference.
a Adjusted by age, smoking, drinking, exercise and income
b Waist circumference ≥ 90cm for men
c Triglyceride ≥ 150 mg/dL or user of lipid-lowering drug
d The value was divided into quartile